<BASE HREF="http://vascular.free.fr/">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<title>Eicosanoids &amp; Vascular Pharmacology</title>
<meta name=viewport content="width=device-width, initial-scale=1">
</head>
<style type="text/css">
<!--
.Style4 {font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px; }
.Style32 {font-size: 12px}
.Style16 {font-size: xx-small}
.Style9 {font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 14px; font-weight: bold; }
.Style71 {font-family: Verdana, Arial, Helvetica, sans-serif}
.Style76 {font-weight: bold; font-size: xx-small; font-family: Verdana, Arial, Helvetica, sans-serif; }
.Style77 {font-size: 10px}
.Style79 {font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 16px; font-weight: bold; }
.Style80 {
	font-size: 12px;
	font-weight: bold;
}
.Style70 {font-size: 18px; color: #000000;}
.Style22 {font-size: 16px;
	color: #9900CC;
	font-style: italic;
	font-weight: bold;
}
.Style35 {font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px; font-weight: bold; }

body {
	background-image: url();
}
.Style82 {
	font-size: 36px;
	font-family: Verdana, Arial, Helvetica, sans-serif;
	font-weight: bold;
	font-style: italic;
}
.Style83 {color: #FF0000}
.Style84 {
	font-family: Verdana, Arial, Helvetica, sans-serif;
	font-size: 12px;
	font-weight: bold;
	font-style: normal;
}
-->
</style>
<script language="JavaScript" type="text/JavaScript">
<!--



function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}
//-->
</script>
<body>
<table width="78%" border="2" align="center" bordercolor="#999999" background="gris111.jpg">
  <tr bordercolor="#999999" background="gris111.jpg">
    <th colspan="6" align="center" valign="middle" bordercolor="#999999" background="gris111.jpg" scope="col"><h1><span class="Style82"><font color="#ff0000">Eicosanoids &amp; Vascular Pharmacology</font></span> </h1>
      <p class="Style79"><b>Human vascular tissue research<br>
      </b>Welcome to our homepage, enjoy your visit!
      </p>      
      <div align="center">
      <table align="center">
          <tr align="center">
            <td width="51" class="Style71"><div align="center"><a href="https://www.hon.ch/HONcode/Conduct.html?HONConduct962138" onClick="window.open(this.href); return false;" ><img src="http://www.hon.ch/HONcode/Seal/HONConduct962138_s.gif" alt="This website is certified by Health On the Net Foundation. Click to verify." width="49" height="72" align="bottom" style="border:0px" title="This website is certified by Health On the Net Foundation. Click to verify." /></a></div></td>
            <td width="720" class="Style76" ><p align="left" class="Style19  Style32"><b><span class="Style77"><b>Host</b> <b>laboratory for BA, Master and PhD Thesis, contact: </b> <b><a href="mailto:xnorel@hotmail.com"> xnorel@hotmail.com</a>,&nbsp; INSERM <a href="http://www.u1148.fr/">U1148</a>, </b><b><b>Laboratory for Vascular Translational Science (LVTS)</b>.</b> CHU X. Bichat, 46, rue Henri Huchard, 75877 Paris Cedex 18, France. <b>Access, <a href="../planBichat.jpg" target="_blank">map</a>. </b> Tel: 33 1 40 25 75 29, Fax: 33 1 40 25 86 02</span></b><span class="Style77">.<br>
        We comply with the <a href="http://www.hon.ch/HONcode/Conduct.html" onClick="window.open(this.href); return false;"> HONcode standard for trustworthy health</a> information: <a href="https://www.hon.ch/HONcode/Conduct.html?HONConduct962138" onClick="window.open(this.href); return false;">verify here</a>. Webmaster: X. Norel<font color="#000000"> (PhD). &copy;2018-2021 Eicosanoids & Vasc. Pharmacol. <a href="../pge/legalInfo.htm">about the website <br>
        </a></font>Last update:
        <!-- #BeginDate format:Fr1 -->28/05/19<!-- #EndDate -->
    </span></p></td>
          </tr>
        </table>
    </div>      </th>
    <th align="center" valign="middle" background="gris111.jpg" scope="col"><div align="center"><font size="6" face="Arial Narrow"><b>	<img src="logovassfond.gif" width="150" height="248" border="0" align="right" usemap="#Map"></b></font></div></th>
  </tr>
  <tr valign="middle" bordercolor="#999999" class="Style76" background="../gris111fonce.jpg">
    <td width="92" height="52"><div align="center" class="Style80">
    <span class="Style19 Style71 "><strong><span class="Style25"><a href="index.htm">Home</a></span></strong></span></div></td>
    <td width="182"><div align="center" class="Style19 Style71 Style32">      
      <strong><span class="Style25"><a href="../pge/Pulmonary-Vessel-Prostanoid-Receptors-Human.htm">Prostanoid receptors<br>
    in human pulmonary vessels</a></span></strong></div></td>
    <td width="149"><div align="center" class="Style19 Style71 Style32">      
      <strong><span class="Style25"><a href="../pge/Prostanoid-Receptors-Human-Vessels.htm">Prostanoid receptors<br>
    in human vessels</a></span></strong></div></td>
    <td width="199"><div align="center" class="Style19 Style71 Style32">      
      <strong><span class="Style25"><a href="../pge/Cholinergic.htm">Cholinergic control<br> 
    in human pulmonary vessels</a></span></strong></div></td>
    <td width="178"><div align="center" class="Style19 Style71 Style32">      
      <strong><span class="Style25"><a href="../pge/Leukotriene.htm">Leukotriene receptors<br>
        in human pulmonary vessels</a></span></strong></div>      
    <div align="center" class="Style19 Style71 Style32">      
      </div>      <div align="center" class="Style19 Style71 Style32">      
    </div></td>
    <td width="81"><div align="center" class="Style32"><strong><a href="../pge/Labo.htm" class="Style25">Laboratory &amp; Links</a></strong></div></td>
    <td width="158" align="center"><div align="center" class="Style32">
    <span class="Style19 Style71 "><strong><span class="Style25"><a href="../pge/Publications.htm">Publications</a></span></strong></span></div></td>
  </tr>
  <tr valign="middle" class="Style16" background="gris111clair.jpg">
    <td colspan="7"><div align="center">
      <br>
      <table width="932" border="0">
        <tr>
          <td width="926"><p align="center" class="Style9"><span class="Style71"><u>Introduction</u></span><u><span class="Style23 Style26 Style69"><span class="Style70"></span></span></u></p>
            <p align="justify" class="Style9"><span class="Style23 Style26 Style69"><span class="Style70"><span class="Style32"> </span></span></span><span class="Style23 Style26 Style69"><span class="Style32">Eicosanoids are metabolites of arachidonic acid derived from the action of the cyclooxygenase (<a href="../cox-pathway.jpg">cyclooxygenase pathway</a><font color=#000000>) or lypoxygenase enzymatic pathways. These metabolites may control the smooth muscle tone, the cell proliferation and migration </font>in human vascular bed. Most of our present studies concern the 8 different prostanoid receptor subtypes (DP, EP1-4, FP, IP, TP) activated by prostaglandins and/or thromboxane and the enzymatic activities ( COX-1, COX-2, mPGES...) involved in the cyclooxygenase pathway. The roles of prostanoids in the human vascular wall are investigated in physiological and pathophysiological conditions (pulmonary hypertension, systemic hypertension, varicosity, atherosclerosis, aneurysm, preeclamsia). </span></span></p></td>
        </tr>
      </table>
      <table width="625" border="1" cellpadding="10" cellspacing="0" bordercolor="orange">
        <tr align="center">
          <td width="601"><p align="center" class="Style84"><strong><a href="https://ed-galilee.univ-paris13.fr/wp-content/uploads/Sujet-LVTS-2-Norel.pdf">Sujet de Th&egrave;se&nbsp;ED Galil&eacute;e Universit&eacute; PAris 13 :<br>
            R&ocirc;le des &laquo;&nbsp;Specialized Pro-resolving Mediators&nbsp;&raquo; et de la prostaglandine  E2<br>
            dans le c&oelig;ur et les coronaires humaines
          </a></strong></p>
            </td>
        </tr>
      </table>
      <p><a href="http://bioactivelipids.org/" target="_blank"><img src="../Banner_Bioactive Lipids - St. Pete Confss.jpg" width="560" height="121" alt=""/></a><br>
        <a href="http://bioactivelipids.org/" target="_blank"><span class="Style9">16th International Conference: Bioactive Lipids in Cancer, Inflammation and Related Diseases</span></a>        <br>
      </p>
      <div align="center">
        <div align="center"><strong><FONT face="Tahoma"><span class="Style22"><SPAN style="font-family: Tahoma;" lang="EN-GB"><u></u></SPAN></span></FONT> </strong></div>
    </div>
    </div>      <div align="center"><center><div align="right" class="Style4">
      <dl>
              <dd>
                <table width="843" border="0" align="center">
                  <tr>
                    <td align="center"><div align="center">-------------------------------------------------------------------- </div></td>
                  </tr>
                  <tr>
                    <td width="837" align="center"><div align="left">
                      <p class="Style35"><strong>LAST PUBLICATIONS of the RESEARCH GROUP:</strong></p>
                      <p class="Style84"><em><strong><u>Reviews</u></strong></em><br>
                        <br>
                        <em style="font-style: normal"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650665/" target="_blank">THE  CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview. </a>Br J Pharmacol. 2017 Dec;174  Suppl 1:S1-S16. doi: 10.1111/bph.13882. PubMed PMID: 29055037; PubMed Central  PMCID: PMC5650665.</em></p>
                      <p class="Style35"><a href="https://www.ncbi.nlm.nih.gov/pubmed/28347710" target="_blank">Prostanoids in the pathophysiology of human coronary artery.</a> Prostaglandins Other Lipid Mediat. <a href="../CoroReview.pdf" target="_blank"><span class="Style83">PDF </span></a>2017 Mar 24.  pii: S1098-8823(16)30160-5. doi: 10.1016/j.prostaglandins.2017.03.003. [Epub ahead of print] Review. PubMed PMID: 28347710.</p>
                      <p class="Style35"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26424111" target="_blank">Human perivascular adipose tissue dysfunction as a cause of vascular disease: Focus on vascular tone and wall remodeling.</a> Eur J Pharmacol. <a href="../EJPfinal.pdf" target="_blank"><span class="Style83">PDF</span></a> 2015 Nov 5;766:16-24. <a href="../EJPfinal.pdf" target="_blank"></a> doi: 10.1016/j.ejphar.2015.09.012. Epub 2015 Sep 28. Review. PubMed PMID: 26424111. </p>
                      <p class="Style35"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26650438" target="_blank">The Concise Guide to PHARMACOLOGY 2015/16, Overview:</a> Br J Pharmacol.  2015 Dec;172(24):5729-43. doi: 10.1111/bph.13347. PubMed PMID: 26650438; PubMed Central PMCID: PMC4718217. <a href="../Alexander_et_al-2015-British_Journal_of_Pharmacology.pdf" target="_blank" class="Style83">PDF</a> GPCR.</p>
                      <p class="Style35"> <a href="https://www.ncbi.nlm.nih.gov/pubmed/23756023" target="_blank">The role of prostaglandin E2 in human vascular inflammation.</a> Prostaglandins Leukot Essent Fatty Acids. <a href="../RevuePLEFA2013.pdf" target="_blank" class="Style83">PDF</a> 2013 Aug;89(2-3):55-63. doi: 10.1016/j.plefa.2013.04.004. Epub 2013 Jun 4. Review. PubMed PMID: 23756023.</p>
                      <p class="Style35"><a href="https://www.ncbi.nlm.nih.gov/pubmed/17767355">Prostanoid receptors in the human vascular wall.</a>                        ScientificWorldJournal. <a href="../546383.pdf" target="_blank" class="Style83">PDF</a> 2007 Sep 1;7:1359-74. Review. PubMed PMID: 17767355.</p>
                      <p class="Style84"><u>Data publications </u><br>
                        <a href="https://www.ncbi.nlm.nih.gov/pubmed/30349011" target="_blank"><br>
                        Inflammation increases MMP levels via PGE(2) in human vascular wall and plasma of obese women.</a> <span class="Style83"><a href="../s41366-018-0235-6-2.pdf" target="_blank" class="Style83">PDF</a></span>  Int J Obes (Lond). 2018 Oct 22.
doi: 10.1038/s41366-018-0235-6. [Epub ahead of print] PubMed PMID: 30349011.</p>
                      <p class="Style84"><span class="Style35"><a href="https://www.ncbi.nlm.nih.gov/pubmed/29800147" target="_blank">Neutrophils recruited by leukotriene B4 induce  features of plaque destabilization during endotoxemia. </a>
  Cardiovasc Res. 2018 May  24. doi: 10.1093/cvr/cvy130. [Epub ahead of print] PubMed PMID: 29800147.</span></p>
                      <p class="Style84">   
                        <a href="http://onlinelibrary.wiley.com/doi/10.1111/bph.13939/epdf">
                          I</a><a href="http://onlinelibrary.wiley.com/doi/10.1111/bph.13939/epdf" class="Style35">nhibition of microsomal PGE  synthase-1 reduces human vascular tone by increasing PGI(2) : a safer alternative  to COX-2 inhibition.</a> 
  <span class="Style35">Br J Pharmacol. 2017 Nov;174(22):4087-4098. doi:  10.1111/bph.13939. Epub 2017 Aug 11. PubMed PMID: 28675448.</span></p>
                      <span class="Style84"><a href="https://www.ncbi.nlm.nih.gov/pubmed/28373136" target="_blank" class="Style35">Decreased vasorelaxation induced by iloprost during acute inflammation in human internal mammary artery.</a> <span style="font-style: normal">Eur J Pharmacol. 2017
Mar 31. pii: S0014-2999(17)30229-7. doi: 10.1016/j.ejphar.2017.03.060. [Epub ahead of print] PubMed PMID: 28373136.</span></span>                      
                      <p class="Style35"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27362269" target="_blank">Reverse
                          Regulatory Pathway (H2S / PGE2 / MMP) in Human Aortic Aneurysm and Saphenous Vein
                          Varicosity.</a> PLoS One. <a href="../journal.pone.0158421.pdf" target="_blank"><span class="Style83">PDF</span></a> 2016 Jun 30;11(6):e0158421.  doi:
                        10.1371/journal.pone.0158421. eCollection 2016. PubMed PMID: 27362269.</p>
                        <p class="Style35"><a href="https://www.ncbi.nlm.nih.gov/pubmed/26362969" target="_blank">Ex vivo relaxations of pulmonary arteries induced by prostacyclin mimetics are highly dependent of the precontractile agents. </a>Prostaglandins Other Lipid Mediat. <a href="../FinalChabhaPolm.pdf" target="_blank" class="Style83">PDF</a> 2015 Sep;121(Pt A):46-52. doi: 10.1016/j.prostaglandins.2015.09.002. Epub 2015 Sep 8. PubMed PMID: 26362969.</p>
                        <p>                          <span class="Style35"><a href="https://www.ncbi.nlm.nih.gov/pubmed/24505358" target="_blank">Decreased PGE2 content reduces MMP-1 activity and consequently increases collagen
                          density in human varicose vein. </a>PLoS One. 2014 Feb 5;9(2):e88021. doi:
                          10.1371/journal.pone.0088021. eCollection <a href="../journal.pone.0088021.pdf" target="_blank" class="Style83">PDF</a> 2014. PubMed PMID: 24505358; PubMed<br>
                        Central PMCID: PMC3914898<a href="../SPM_PG_ThesisProject.pdf" target="_blank">.</a><a href="../" target="_blank"></a></span></p>
                        <p class="Style35">&nbsp;</p>
                        </div></td>
                  </tr>
                </table>
              </dd>
              <dt>
                <div align="center"></div>
              </dt>
            </dl>
           
          </div>
          <p class="Style9">&nbsp;</p>
        </center>
    </div></td>
  </tr>
</table>
</body>
</html>